Andrew G. Day

Andrew Day has 25 years of experience as a biostatistician supporting health research. Mr. Day has been senior biostatistician for the Kingston General Health Research Institute (KGHRI) and the Clinical Evaluation Research Unit for the past 18 years and was previously a biostatistician for 7 years at the Canadian Cancer Trials Group.

As Senior Biostatistician for the KGHRI, Mr. Day has collaborated with hundreds of researchers. He has been responsible for the statistical aspects of the design, conduct, analysis and reporting for more than 300 diverse studies including more than 50 Randomized Controlled Trials (RCTs). He was co-applicant, lead statistical methodologist and senior author for two major international RCTs published in the New England Journal of Medicine and was responsible for the statistical design, analysis and write-up of the largest cluster RCT published in the ICU literature.

Mr. Day has been a co-investigator on 37 peer reviewed grant applications receiving $25 million from the Canadian Institutes of Health Research (CIHR) and $15 million from other sources. He has co-authored nearly 200 publications.

Mr. Day has supervised graduate students, mentored biostatisticians, and taught graduate courses in the departments of Public Health Sciences and Mathematics and Statistics at Queen’s University. Since 2007, Mr. Day has served as a member of the CIHR RCT Committee where he has been the statistical reviewer for over 100 applications. Mr. Day serves on the data monitoring committees of several RCTs and is a regular statistical reviewer for medical journals.